A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma

Molecular Biology Reports

Volumn 39, Issue 1, 2012, Pages 157-165

  Seo, Gwi Moon ^a   Rachakatla, Raja Shekar ^a   Balivada, Sivasai ^a   Pyle, Marla ^a   Shrestha, Tej B ^a   Basel, Matthew T ^a   Myers, Carl ^a   Wang, Hongwang ^a   Tamura, Masaaki ^a   Bossmann, Stefan H ^a   Troyer, Deryl L ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

B16 F10; Mouse lung melanoma; Mouse monocytes; Suicide therapy; Targeted cell delivery

Indexed keywords

CARBOXYLESTERASE; DOXYCYCLINE; IRINOTECAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PRODRUG THERAPY; FEMALE; LUNG CANCER; LUNG WEIGHT; MELANOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARBOXYLESTERASE; CELL TRANSPLANTATION; DNA PRIMERS; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; FEMALE; GENES, TRANSGENIC, SUICIDE; LUNG NEOPLASMS; MAGNETICS; MELANOMA; MICE; MICE, INBRED C57BL; MONOCYTE-MACROPHAGE PRECURSOR CELLS; NANOPARTICLES; PRODRUGS;

EID: 84855195861     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0720-7     Document Type: Article

References (43)

1. RG Azrak S Cao HK Slocum K Toth FA Durrani MB Yin L Pendyala W Zhang HL McLeod YM Rustum 2004 Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts Clin Cancer Res 10 1121 1129 14871992 10.1158/1078-0432.CCR-0913-3 1:CAS:528:DC%2BD2cXhtFCnsr4%3D (Pubitemid 38198914)
2. M Rooseboom JN Commandeur NP Vermeulen 2004 Enzyme-catalyzed activation of anticancer prodrugs Pharmacol Rev 56 53 102 15001663 10.1124/pr.56.1.3 1:CAS:528:DC%2BD2cXivFymtb4%3D (Pubitemid 38314580)
3. F Friedlos WA Denny BD Palmer CJ Springer 1997 Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapy J Med Chem 40 1270 1275 9111301 10.1021/jm960794l 1:CAS:528: DyaK2sXhvFyisL4%3D (Pubitemid 27175106)
4. O Greco GU Dachs 2001 Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives J Cell Physiol 187 22 36 11241346 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H 1:CAS:528:DC%2BD3MXhs1Kqtb8%3D (Pubitemid 32195242)
5. Y Liu H Miyoshi M Nakamura 2007 Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles Int J Cancer 120 2527 2537 17390371 10.1002/ijc.22709 1:CAS:528:DC%2BD2sXkslGitLc%3D (Pubitemid 46651272)
6. KS Aboody A Brown NG Rainov KA Bower S Liu W Yang JE Small U Herrlinger V Ourednik PM Black XO Breakefield EY Snyder 2000 Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas Proc Natl Acad Sci USA 97 12846 12851 11070094 10.1073/pnas.97.23.12846 1:CAS:528:DC%2BD3cXotFyksrc%3D
7. M Studeny FC Marini RE Champlin C Zompetta IJ Fidler M Andreeff 2002 Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors Cancer Res 62 3603 3608 12097260 1:CAS:528:DC%2BD38XltF2jt70%3D (Pubitemid 34728832)
8. M Studeny FC Marini JL Dembinski C Zompetta M Cabreira-Hansen BN Bekele RE Champlin M Andreeff 2004 Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents J Natl Cancer Inst 96 1593 1603 15523088 10.1093/jnci/djh299 1:CAS:528:DC%2BD2cXhtVeqs7nM (Pubitemid 39534883)
9. RS Rachakatla F Marini ML Weiss M Tamura D Troyer 2007 Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors Cancer Gene Ther 14 828 835 17599089 10.1038/sj.cgt.7701077 1:CAS:528:DC%2BD2sXhtVagtbbM (Pubitemid 47402382)
10. RS Rachakatla MM Pyle R Ayuzawa SM Edwards FC Marini ML Weiss M Tamura D Troyer 2008 Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs Cancer Invest 26 662 670 18608205 10.1080/07357900701871134 1:CAS:528:DC%2BD1cXpt1ensrY%3D
11. C Ganta D Chiyo R Ayuzawa R Rachakatla M Pyle G Andrews M Weiss M Tamura D Troyer 2009 Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation Cancer Res 69 1815 1820 19244122 10.1158/0008-5472.CAN-08-2750 1:CAS:528:DC%2BD1MXisFSrt70%3D
12. AS Arbab SD Pandit SA Anderson GT Yocum M Bur V Frenkel HM Khuu EJ Read JA Frank 2006 Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis Stem Cells 24 671 678 16179427 10.1634/stemcells.2005-0017 1:CAS:528:DC%2BD28XhtFKitbbF
13. M De Palma R Mazzieri LS Politi F Pucci E Zonari G Sitia S Mazzoleni D Moi MA Venneri S Indraccolo A Falini LG Guidotti R Galli L Naldini 2008 Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis Cancer Cell 14 299 311 18835032 10.1016/j.ccr.2008. 09.004
14. B Huang A Desai S Tang TP Thomas JR Baker Jr 2010 The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release Org Lett 12 1384 1387 20192275 10.1021/ol1002626 1:CAS:528:DC%2BC3cXisFGmtLo%3D
15. T Matsuzaki T Yokokura M Mutai T Tsuruo 1988 Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice Cancer Chemother Pharmacol 21 308 312 3370738 10.1007/BF00264196 1:CAS:528:DyaL1cXkvVGrsLg%3D
16. K Arimori N Kuroki A Kumamoto N Tanoue M Nakano E Kumazawa A Tohgo M Kikuchi 2001 Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents Pharm Res 18 814 822 11474786 10.1023/A:1011040529881 1:CAS:528:DC%2BD3MXlt1Cqtbc%3D (Pubitemid 32783518)
17. S O'Reilly EK Rowinsky 1996 The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996 Crit Rev Oncol Hematol 24 47 70 8869798 10.1016/1040-8428(96)00211-9 (Pubitemid 26337054)
18. KS Aboody RA Bush E Garcia MZ Metz J Najbauer KA Justus DA Phelps JS Remack KJ Yoon S Gillespie SU Kim CA Glackin PM Potter MK Danks 2006 Development of a tumor-selective approach to treat metastatic cancer PLoS One 1 e23 17183650 10.1371/journal.pone.0000023
19. MK Danks CL Morton EJ Krull PJ Cheshire LB Richmond CW Naeve CA Pawlik PJ Houghton PM Potter 1999 Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy Clin Cancer Res 5 917 924 10213229 1:CAS:528:DyaK1MXislOnsbY%3D (Pubitemid 29180845)
20. MK Danks KJ Yoon RA Bush JS Remack M Wierdl L Tsurkan SU Kim E Garcia MZ Metz J Najbauer PM Potter KS Aboody 2007 Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma Cancer Res 67 22 25 17210679 10.1158/0008-5472.CAN-06-3607 1:CAS:528:DC%2BD2sXisFSnsQ%3D%3D (Pubitemid 46142755)
21. R Humerickhouse K Lohrbach L Li WF Bosron ME Dolan 2000 Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2 Cancer Res 60 1189 1192 10728672 1:CAS:528:DC%2BD3cXhvFWrsb8%3D (Pubitemid 30151980)
22. G Zhang Y Liao I Baker 2010 Surface engineering of core/shell iron/iron oxide nanoparticles from microemulsions for hyperthermia Mater Sci Eng C 30 92 97 10.1016/j.msec.2009.09.003
23. S Balivada RS Rachakatla H Wang TN Samarakoon RK Dani M Pyle FO Kroh B Walker X Leaym OB Koper M Tamura V Chikan SH Bossmann DL Troyer 2010 A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study BMC Cancer 10 119 20350328 10.1186/1471-2407-10-119
24. S Sawada S Okajima R Aiyama K Nokata T Furuta T Yokokura E Sugino K Yamaguchi T Miyasaka 1991 Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin Chem Pharm Bull (Tokyo) 39 1446 1450 1:CAS:528:DyaK3MXlvVeltr0%3D
25. S Sawada T Yokokura T Miyasaka 1995 Synthesis and antitumor activity of A-ring or E-lactone modified water-soluble prodrugs of 20(S)-camptothecin, including development of irinotecan hydrochloride trihydrate (CPT-11) Curr Pharm Design 1 113 132 1:CAS:528:DyaK28XovVeruw%3D%3D
26. Miyasaka T, Sawada S, Nokata K, Sugino E, Mutai M (1986) Camptothecin derivatives and process for preparing same. US Patent #4,604,463
27. MH Wu B Yan R Humerickhouse ME Dolan 2002 Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells Clin Cancer Res 8 2696 2700 12171903 1:CAS:528:DC%2BD38XmvVaht74%3D (Pubitemid 34856359)
28. F Innocenti SD Undevia L Iyer PX Chen S Das M Kocherginsky T Karrison L Janisch J Ramirez CM Rudin EE Vokes MJ Ratain 2004 Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan J Clin Oncol 22 1382 1388 15007088 10.1200/JCO.2004.07.173 1:CAS:528:DC%2BD2cXpt1yjtbk%3D (Pubitemid 41103619)
29. J van Ark-Otte MA Kedde WJ van der Vijgh AM Dingemans WJ Jansen HM Pinedo E Boven G Giaccone 1998 Determinants of CPT-11 and SN-38 activities in human lung cancer cells Br J Cancer 77 2171 2176 9649129 10.1038/bjc.1998.362 (Pubitemid 28263937)
30. D Oosterhoff HM Pinedo IH van der Meulen M de Graaf T Sone FA Kruyt VW van Beusechem HJ Haisma WR Gerritsen 2002 Secreted and tumour targeted human carboxylesterase for activation of irinotecan Br J Cancer 87 659 664 12237777 10.1038/sj.bjc.6600519 1:CAS:528:DC%2BD38XntVKjs78%3D
31. MC Bissery P Vrignaud F Lavelle GG Chabot 1996 Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice Anticancer Drugs 7 437 460 8826613 10.1097/00001813-199606000-00010 1:CAS:528:DyaK28XkslWqsrw%3D (Pubitemid 26249198)
32. MC Bissery P Vrignaud F Lavelle GG Chabot 1996 Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing mice Ann N Y Acad Sci 803 173 180 8993510 10.1111/j.1749-6632.1996.tb26386.x 1:CAS:528:DyaK2sXhtV2htL0%3D (Pubitemid 27057984)
33. N Kaneda H Nagata T Furuta T Yokokura 1990 Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse Cancer Res 50 1715 1720 2306725 1:CAS:528:DyaK3cXitFSnurk%3D (Pubitemid 20098809)
34. PG Tardi N Dos Santos TO Harasym SA Johnstone N Zisman AW Tsang DG Bermudes LD Mayer 2009 Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo Mol Cancer Ther 8 2266 2275 19671743 10.1158/1535-7163.MCT-09-0243 1:CAS:528:DC%2BD1MXpvFCmsr4%3D
35. M Zabala L Wang R Hernandez-Alcoceba W Hillen C Qian J Prieto MG Kramer 2004 Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors Cancer Res 64 2799 2804 15087396 10.1158/0008-5472.CAN-03-3061 1:CAS:528:DC%2BD2cXjtV2ltb4%3D (Pubitemid 38500618)
36. D Reuveni D Halperin I Fabian G Tsarfaty N Askenasy I Shalit 2010 Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors Biochem Pharmacol 79 1100 1107 20025849 10.1016/j.bcp.2009.12.001 1:CAS:528:DC%2BC3cXitVOhsLk%3D
37. G Solinas G Germano A Mantovani P Allavena 2009 Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation J Leukoc Biol 86 1065 1073 19741157 10.1189/jlb.0609385 1:CAS:528:DC%2BD1MXhtlyjs7vL
38. HM Strik P Hulper B Erdlenbruch J Meier A Kowalewski B Hemmerlein R Gold M Bahr 2006 Models of monocytic invasion into glioma cell aggregates Anticancer Res 26 865 871 16619481
39. S Valable EL Barbier M Bernaudin S Roussel C Segebarth E Petit C Remy 2008 In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma Neuroimage 40 973 983 18441552 10.1016/j.neuroimage.2008.01.005
40. B Burke S Sumner N Maitland CE Lewis 2002 Macrophages in gene therapy: cellular delivery vehicles and in vivo targets J Leukoc Biol 72 417 428 12223508 1:CAS:528:DC%2BD38XntlOnurg%3D
41. B Burke 2003 Macrophages as novel cellular vehicles for gene therapy Expert Opin Biol Ther 3 919 924 12943451 10.1517/14712598.3.6.919 1:CAS:528:DC%2BD3sXmslSit7Y%3D (Pubitemid 37093147)
42. B Burke A Giannoudis KP Corke D Gill M Wells L Ziegler-Heitbrock CE Lewis 2003 Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy Am J Pathol 163 1233 1243 14507633 10.1016/S0002-9440(10)63483-9 1:CAS:528:DC%2BD3sXotlegsb8%3D (Pubitemid 37175073)
43. BL Barthel Z Zhang DL Rudnicki CD Coldren M Polinkovsky H Sun GG Koch DC Chan TH Koch 2009 Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine J Med Chem 52 7678 7688 19634903 10.1021/jm900694z 1:CAS:528:DC%2BD1MXptVCksbc%3D